NAZANIN ANVARI: Open Payments
NPI 1467976837 · NEWPORT BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$360 in 11 payments from 6 companies in 2025. Trend: 2023 $252 · 2024 $437 · 2025 $360
Food & beverage: $360
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 6 | $146 |
| PFIZER INC. | 1 | $125 |
| Boston Scientific Corporation | 1 | $39 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| Caris MPI, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: LYNPARZA, TIVDAK, WaveWriter Alpha Prime 16, MI CANCER SEEK, JEMPERLI, KEYTRUDA.
Industry payments across CA — which companies pay providers there.
